Acronym: TRANSCAN
Period: January 2011 till December 2014
Status: Completed
|
|
| Institutes (22) |
Top |
- Ministry of development; General Secretariat for Research and Innovation (GSRT), more
- The Research Council of Norway (RCN), more
- Ministério da Ciência e da Tecnologia; Foundation for Science and Technology (FCT), more
- Slovak Academy of Sciences, more
- Scientific and Technological Research Council of Turkey (TÜBITAK), more
- Ministry of Health; Hellenic Centre for Disease Control & Prevention (HCDCP), more
- Ministry of Health (MOH), more
- National Institute of Health (ISS), more
- Masaryk Memorial Cancer Institute (MMCI), more
- Federal Ministry of Education and Research (BMBF), more
- Ministry of Health; Alliance Against Cancer (ACC), more
- Ministry of Education, University and Research (MIUR), more
- Latvian Academy of Sciences (LAS), more
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Nederlandse organisatie voor gezondheidsonderzoek en zorginnovatie (ZonMw), more
- National Centre for Research and Development (NCBiR), more
- Institute of Oncology (IOB), more
- Ministry of Education, Science and Sport (MIZS), more
- Spanish Ministry of Economy and Competiveness; Instituto de Salud Carlos III (ISCIII), more
- Cancer Research UK (CR-UK), more
- Ministry of Health; National Institute of Oncology (NIO), more
- German Aerospace Centre; Project Management Agency on Environment, Culture & Sustainability (DLR), more
- Ministry of health; Chief Scientist Office (CSO), more
|
| Abstract |
TRANSCAN is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 25 partners from 19 European and Associated countries.
Objective
To contribute to the building of the European Research Area through the coordination of activities of national and regional translational cancer research funding organisations, aiming at the integration of basic, clinical and epidemiological cancer research and facilitation of transnational cancer funding in Europe with the ultimate aim to streamline EU-wide cancer screening, early diagnosis, prognosis, treatment and care. |
|
